Diagnostic algorithm and reasonable therapy of patients with obstructive sleep apnea and resistant arterial hypertension


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Obstructive sleep apnea (OSA), being an independent disease, is closely interrelated with comorbid pathology, such as obesity, arterial hypertension (AH), impaired carbohydrate metabolism, dyslipidemia. СРАР-therapy (Continuous Positive Airway Pressure or CPAP therapy) is the fundamental therapeutic doctrine of patients with OSA. However, the effects of CPAP therapy on normalization of blood pressure and dyslipidemia in OSA patients with resistant arterial hypertension (RAH) remain poorly understood and underused in practice of the therapist. Objective. The purpose of this publication is to demonstrate a reasonable diagnostic and treatment strategy of drug and drug-free treatment of OSA-patients, using the example of a comorbid patient OSA+RAH. Conclusions. Modern diagnostic algorithms for OSA patients are realistic and workable in everyday medical practice. They allow you to perform a reliable diagnosis of sleep apnea in a hospital or outpatient. Long-term CPAP therapy in patients with OSA+RAH is lifesaving technology with a high compliance and clinical effect. It is necessary to expand the boundaries of the early use of CPAP therapy, especially in OSA patients with comorbid pathology.

Full Text

Restricted Access

About the authors

M. V Gorbunova

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Sergey L. Babak

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: sergbabak@mail.iu
MD, Professor, Department of Phthisiology and Pulmonology

A. G Malyavin

A.I. Evdokimov Moscow State University of Medicine and Dentistry

References

  1. Obstructive Sleep Apnea Syndrome (780.53-0). The International Classification of Sleep Disorders. American Academy of Sleep Medicine. 2010. Р. 52-8
  2. Farney R.J., Walker B.S., Farney R.M., et al. The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: relation to polysomnographic measurements of the apnea/hypopnea index. J Clin Sleep Med. 2011;7(5):459-65. doi: 10.5664/JCSM.1306.
  3. Lombardi C., Tobaldini E., Montano N., et al. Obstructive Sleep Apnea Syndrome (OSAS) and Cardiovascular System. Med Lav. 2017;108(4):276-82. doi: 10.23749/mdl. v108i4.6427. PMID: 28853425.
  4. Floras J.S. Hypertension and Sleep Apnea. Can J. Cardiol. 2015;31(7):889-97. Doi: 10.1016/j. cjca.2015.05.003. PMID: 26112299.
  5. Khan A., Patel N.K., O’Hearn D.J., Khan S. Resistant hypertension and obstructive sleep apnea. Int J. Hypertens. 2013;2013:193010. doi: 10.1155/2013/193010.
  6. Logan AG, Perlikowski S.M., Mente A., et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens. 2001;19(12):2271-77.
  7. Walia H.K., Li H., Rueschman M., et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J. Clin Sleep Med. 2014;10(8):835-43. doi: 10.5664/jcsm.3946.
  8. Pedrosa R.P., Drager L.F., Gonzaga C.C., et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811-17. Doi: 10.1161/ HYPERTENSIONAHA.111.179788.
  9. Sullivan C.E., Issa EG., Berthon-Jones M., Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862-65. PMID: 6112294.
  10. Varounis C., Katsi V., Kallikazaros I.E., et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. Int J. Cardiol. 2014;175(1):195-98. Doi: 10.1016/j. ijcard.2014.04.240.
  11. Martfnez-Garcfa M.A., Capote F., Campos-Rodrfguez F., et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407-15. doi: 10.1001/jama.2013.281250.
  12. Sapina E., Torres G., Barbe F., et al. The Use of Precision Medicine to Manage Obstructive Sleep Apnea Treatment in Patients with Resistant Hypertension: Current Evidence and Future Directions. Curr Hypertens Rep. 2018;20(7):60. doi: 10.1007/s11906-018-0853-3.
  13. Joyeux-Faure M., Baguet J.P., Barone-Rochette G., et al. Continuous Positive Airway Pressure Reduces Night-Time Blood Pressure and Heart Rate in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The RHOOSAS Randomized Controlled Trial. Front Neurol. 2018;9:318. doi: 10.3389/fneur.2018.00318.
  14. Chung F., Abdullah H.R., Liao P. STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea. Chest. 2016;149(3):631-38. doi: 10.1378/chest. 15-0903.
  15. Nagappa M., Wong J., Singh M., et al. An update on the various practical applications of the STOP-Bang questionnaire in anesthesia, surgery, and perioperative medicine. Curr Opin Anaesthesiol. 2017;30(1):118-25. Doi: 10.1097/ ACO.0000000000000426.
  16. Малявин А.Г., Бабак С.Л., Адашева Т.В. и др. Диагностика и ведение пациентов с резистентной артериальной гипертензией и обструктивным апноэ сна (Клинические рекомендации). Терапия. 2018;1(19):4-42.
  17. Bradley T.D., Floras J.S. Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation. 2003;107:1671-78. doi: 10.1161/01. CIR.0000061757.12581.15

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies